Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease

Abstract Background Radiolabeled antibody 131I-omburtamab was administered intraventricularly in patients with leptomeningeal disease under an institutionally approved study (#NCT03275402). Radiation safety precautions were tailored for individual patients, enabling outpatient treatment based on in-...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Kavya Prasad, Brian E. Serencsits, Bae P. Chu, Lawrence T. Dauer, Maria Donzelli, Ellen Basu, Kim Kramer, Neeta Pandit-Taskar
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	SpringerOpen 2024-07-01
Reeks:	EJNMMI Research
Onderwerpen:	Brain metastases Radiopharmaceutical Radiation safety
Online toegang:	https://doi.org/10.1186/s13550-024-01127-0
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!